Open Targets

Open Targets is committed to improving the way drug discovery targets are selected. They generate target-centric data in human physiology-relevant systems to enhance the strength of causal relationships between targets and diseases in key therapeutic areas such as oncology, immunology, inflammation, and neurodegeneration. They also integrate genome-wide approaches and high-throughput methods to address all relevant targets in the most pertinent cellular systems involved in diseases.